首页> 美国卫生研究院文献>The Journal of Biological Chemistry >Heat Shock Factor 1 (HSF1) Controls Chemoresistance and Autophagy through Transcriptional Regulation of Autophagy-related Protein 7 (ATG7)
【2h】

Heat Shock Factor 1 (HSF1) Controls Chemoresistance and Autophagy through Transcriptional Regulation of Autophagy-related Protein 7 (ATG7)

机译:热激因子1(HSF1)通过转录调节自噬相关蛋白7(ATG7)来控制化学抗性和自噬。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Heat shock factor 1 (HSF1), a master regulator of heat shock responses, plays an important role in tumorigenesis. In this study we demonstrated that HSF1 is required for chemotherapeutic agent-induced cytoprotective autophagy through transcriptional up-regulation of autophagy-related gene ATG7. Interestingly, this is independent of the HSF1 heat shock response function. Treatment of cancer cells with the FDA-approved chemotherapeutic agent carboplatin induced autophagy and growth inhibition, which were significantly increased upon knockdown of HSF1. Mechanistic studies revealed that HSF1 regulates autophagy by directly binding to ATG7 promoter and transcriptionally up-regulating its expression. Significantly, breast cancer patient sample study revealed that a higher ATG7 expression level is associated with poor patient survival. This novel finding was further confirmed by analysis of two independent patient databases, demonstrating a prognostic value of ATG7. Furthermore, a strong positive correlation was observed between levels of HSF1 and ATG7 in triple-negative breast cancer patient samples, thus validating our in vitro findings. This is the first study identifying a critical role for HSF1 in controlling cytoprotective autophagy through regulation of ATG7, which is distinct from the HSF1 function in the heat shock response. This is also the first study demonstrating a prognostic value of ATG7 in breast cancer patients. These findings strongly argue that combining chemotherapeutic agents with autophagy inhibition by repressing HSF1/ATG7 axis represents a promising strategy for future cancer treatment.
机译:热休克因子1(HSF1)是热休克反应的主要调节因子,在肿瘤发生中起重要作用。在这项研究中,我们证明了通过自噬相关基因ATG7的转录上调,HSF1是化学治疗剂诱导的细胞保护性自噬所必需的。有趣的是,这与HSF1热冲击响应功能无关。用FDA批准的化学治疗药物卡铂诱导的癌细胞自噬和生长抑制作用,在敲除HSF1后会明显增加。机理研究表明,HSF1通过直接结合ATG7启动子并转录上调其表达来调节自噬。重要的是,乳腺癌患者样本研究表明,较高的ATG7表达水平与患者生存不良有关。通过分析两个独立的患者数据库进一步证实了这一新颖发现,证实了ATG7的预后价值。此外,在三阴性乳腺癌患者样品中,HSF1和ATG7的水平之间存在很强的正相关性,从而验证了我们的体外研究结果。这是第一项鉴定HSF1在通过调节ATG7来控制细胞保护性自噬中的关键作用的研究,这与HSF1在热激反应中的功能不同。这也是第一个证明ATG7在乳腺癌患者中具有预后价值的研究。这些发现强烈表明,通过抑制HSF1 / ATG7轴将化学治疗剂与自噬抑制相结合代表了未来癌症治疗的有前途的策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号